Pyxis Oncology (PYXS) Short Interest Ratio & Short Volume $1.60 -0.07 (-4.19%) (As of 12/24/2024 05:10 PM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Pyxis Oncology Short Interest DataPyxis Oncology (PYXS) has a short interest of 6.08 million shares, representing 14.79% of the float (the number of shares available for trading by the public). This marks a 4.11% increase in short interest from the previous month. The short interest ratio (days to cover) is 5.2, indicating that it would take 5.2 days of the average trading volume of 794,819 shares to cover all short positions.Current Short Interest6,080,000 sharesPrevious Short Interest5,840,000 sharesChange Vs. Previous Month+4.11%Dollar Volume Sold Short$12.22 millionShort Interest Ratio5.2 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares59,466,000 sharesFloat Size41,120,000 sharesShort Percent of Float14.79%Today's Trading Volume712,764 sharesAverage Trading Volume794,819 sharesToday's Volume Vs. Average90% Short Selling Pyxis Oncology? Sign up to receive the latest short interest report for Pyxis Oncology and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPYXS Short Interest Over TimePYXS Days to Cover Over TimePYXS Percentage of Float Shorted Over Time Ad DTIWill the Nasdaq 100 crash?In a world where some top money managers say you should “diversify” with a basket of stocks to help lower risk in your portfolio… And others say you should focus on only one ticker at a time because you can’t really keep detailed tabs on 10, 20 or more stocks at once… My #1 strategy to play the Nasdaq bull run has shown the power to provide the best of BOTH worlds at the same time. Because it harnesses ONE ticker that bottles up all the firepower of Apple, Nvidia, Tesla and more into one place… While I cannot promise future returns or against losses… This strategy targets major payouts OVERNIGHT!Click here to get the details. Pyxis Oncology Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/20246,080,000 shares $12.22 million +4.1%14.8%5.2 $2.01 11/15/20245,840,000 shares $24.47 million -0.3%13.3%6.1 $4.19 10/31/20245,860,000 shares $20.86 million +19.4%13.3%11.6 $3.56 10/15/20244,910,000 shares $15.91 million +16.4%10.5%10.2 $3.24 9/30/20244,220,000 shares $15.49 million +11.9%9.0%8.7 $3.67 9/15/20243,770,000 shares $14.25 million -1.1%8.1%6.1 $3.78 Get the Latest News and Ratings for PYXS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pyxis Oncology and its competitors with MarketBeat's FREE daily newsletter. 8/31/20243,810,000 shares $14.44 million -5.2%8.2%6.5 $3.79 8/15/20244,020,000 shares $13.79 million +0.8%8.7%6.9 $3.43 7/31/20243,990,000 shares $15.64 million +13.4%8.4%6.9 $3.92 7/15/20243,520,000 shares $11.26 million +52.4%7.4%6.1 $3.20 6/30/20242,310,000 shares $7.65 million No Change4.9%4.2 $3.31 6/15/20242,310,000 shares $8.75 million +5.5%4.9%4.5 $3.79 5/31/20242,190,000 shares $8.19 million +11.7%4.6%3.8 $3.74 5/15/20241,960,000 shares $8.25 million +6.0%4.2%2.9 $4.21 4/30/20241,850,000 shares $8.23 million -16.3%4.0%2.5 $4.45 4/15/20242,210,000 shares $10.48 million -18.2%4.8%2.4 $4.74 3/31/20242,700,000 shares $11.50 million +65.6%6.9%3.1 $4.26 3/15/20241,630,000 shares $8.35 million +21.6%5.3%2.1 $5.12 2/29/20241,340,000 shares $8.52 million +4.7%4.4%2 $6.36 2/15/20241,280,000 shares $7.16 million +63.1%4.2%2.2 $5.59 1/31/2024784,600 shares $2.99 million +28.4%2.6%2 $3.81 1/15/2024611,100 shares $1.44 million -3.6%2.0%3.2 $2.35 12/31/2023634,000 shares $1.14 million -6.0%2.1%4.4 $1.80 12/15/2023674,600 shares $1.17 million -9.6%2.2%5.3 $1.73 11/30/2023745,800 shares $1.19 million -6.9%2.5%5.8 $1.59 11/15/2023801,100 shares $1.22 million +1.1%2.7%6.4 $1.52 10/31/2023792,500 shares $1.32 million -9.7%2.6%5.9 $1.67 10/15/2023877,300 shares $1.75 million -6.9%2.9%5.8 $2.00 9/30/2023942,400 shares $1.88 million +3.6%3.1%5.3 $1.99 9/15/2023910,100 shares $1.92 million -5.1%3.0%4.2 $2.11 8/31/2023958,600 shares $2.09 million -15.2%3.0%4 $2.18 8/15/20231,130,000 shares $2.76 million -2.6%3.9%3.9 $2.44 7/31/20231,160,000 shares $2.99 million -4.1%4.3%3.1 $2.58 7/15/20231,210,000 shares $3.21 million -60.2%4.5%2.7 $2.65 6/30/20233,040,000 shares $7.78 million -3.5%11.3%4.9 $2.56 6/15/20233,150,000 shares $9.51 million No Change11.7%0.8 $3.02 5/31/20233,150,000 shares $10.14 million +2.6%11.9%0.8 $3.22 5/15/20233,070,000 shares $11.45 million -14.7%11.6%0.8 $3.73 4/30/20233,600,000 shares $10.62 million -23.7%17.9%1 $2.95 4/15/20234,720,000 shares $16.38 million -2.7%23.4%1.3 $3.47We recommended Palantir in 2021, now we’re recommending this... (Ad)My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Click to get the name and ticker symbol 3/31/20234,850,000 shares $19.45 million +5,962.5%25.0%1.4 $4.01 3/15/202380,000 shares $160,800.00 -52.3%0.4%0.5 $2.01 2/28/2023167,700 shares $380,679.00 +49.6%0.8%1.4 $2.27 2/15/2023112,100 shares $173,755.00 -88.5%0.6%0.7 $1.55 1/31/2023973,800 shares $1.52 million +2.8%4.8%5.4 $1.56 1/15/2023947,200 shares $1.45 million +14.7%4.7%5.9 $1.53 12/30/2022826,200 shares $1.11 million +35.7%4.1%4.8 $1.34 12/15/2022609,000 shares $694,260.00 +110.1%3.0%3.7 $1.14 11/30/2022289,800 shares $420,210.00 +80.5%1.4%2 $1.45 11/15/2022160,600 shares $234,476.00 +286.1%0.8%2.1 $1.46 10/31/202241,600 shares $77,792.00 -54.8%0.2%0.7 $1.87 10/15/202292,100 shares $155,649.00 -13.3%0.5%2 $1.69 9/30/2022106,200 shares $209,214.00 -3.1%0.5%2.4 $1.97 9/15/2022109,600 shares $260,848.00 +34.6%0.5%1.1 $2.38 8/31/202281,400 shares $210,826.00 -26.7%0.4%0.8 $2.59 8/15/2022111,000 shares $309,690.00 -7.7%0.5%0.7 $2.79 7/31/2022120,300 shares $318,795.00 -6.7%0.5%0.6 $2.65 7/15/2022128,900 shares $382,833.00 -7.3%0.6%0.6 $2.97 6/30/2022139,000 shares $330,820.00 -69.0%0.6%0.5 $2.38 6/15/2022448,000 shares $1.04 million -6.6%2.0%1.8 $2.33 5/31/2022479,800 shares $1.19 million +37.9%2.2%2.3 $2.47 5/15/2022347,900 shares $702,758.00 +1.4%1.6%2.1 $2.02 4/30/2022343,200 shares $840,840.00 -18.6%1.6%3.3 $2.45 4/15/2022421,500 shares $1.54 million -21.7%2.1%4.1 $3.65 3/31/2022538,500 shares $2.18 million +12.0%2.6%6.9 $4.04 3/15/2022480,700 shares $2.19 million +0.7%2.0%6.7 $4.55 2/28/2022477,500 shares $2.90 million -2.4%2.0%3.7 $6.08 2/15/2022489,400 shares $3.85 million +6.3%2.0%3.6 $7.86 1/31/2022460,300 shares $4.39 million +27.9%1.9%3.1 $9.54 1/15/2022359,800 shares $3.71 million -34.7%1.5%2.3 $10.30 12/31/2021551,200 shares $6.05 million No Change2.3%2.7 $10.97 PYXS Short Interest - Frequently Asked Questions What is Pyxis Oncology's current short interest? Short interest is the volume of Pyxis Oncology shares that have been sold short but have not yet been closed out or covered. As of November 30th, investors have sold 6,080,000 shares of PYXS short. 14.79% of Pyxis Oncology's shares are currently sold short. Learn More on Pyxis Oncology's current short interest. What is a good short interest ratio for Pyxis Oncology? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PYXS shares currently have a short interest ratio of 5.0. Learn More on Pyxis Oncology's short interest ratio. What is a good short interest percentage for Pyxis Oncology? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 14.79% of Pyxis Oncology's floating shares are currently sold short. Is Pyxis Oncology's short interest increasing or decreasing? Pyxis Oncology saw a increase in short interest in November. As of November 30th, there was short interest totaling 6,080,000 shares, an increase of 4.1% from the previous total of 5,840,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Pyxis Oncology's float size? Pyxis Oncology currently has issued a total of 59,466,000 shares. Some of Pyxis Oncology's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Pyxis Oncology currently has a public float of 41,120,000 shares. How does Pyxis Oncology's short interest compare to its competitors? 14.79% of Pyxis Oncology's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Pyxis Oncology: IGM Biosciences, Inc. (15.41%), Taysha Gene Therapies, Inc. (7.65%), Cryoport, Inc. (5.25%), REGENXBIO Inc. (10.62%), Contineum Therapeutics, Inc. (7.40%), GH Research PLC (6.50%), Y-mAbs Therapeutics, Inc. (10.33%), Sana Biotechnology, Inc. (28.79%), Design Therapeutics, Inc. (8.63%), Kamada Ltd. (0.08%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short Pyxis Oncology stock? Short selling PYXS is an investing strategy that aims to generate trading profit from Pyxis Oncology as its price is falling. PYXS shares are trading down $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Pyxis Oncology? A short squeeze for Pyxis Oncology occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PYXS, which in turn drives the price of the stock up even further. How often is Pyxis Oncology's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PYXS, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies IGMS Short Interest Data TSHA Short Interest Data CYRX Short Interest Data RGNX Short Interest Data CTNM Short Interest Data GHRS Short Interest Data YMAB Short Interest Data SANA Short Interest Data DSGN Short Interest Data KMDA Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PYXS) was last updated on 12/26/2024 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk could help pay for your retirementElon Musk is the richest man in the world... And he's pouring trillions into a unique investment.Brownstone Research | SponsoredTSLA *BANG* incoming (bullet in the chamber rn)I just pinpointed 5 dirt-cheap stocks that could soar the second the shot goes off. Thanks to Donald Trump’...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pyxis Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pyxis Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
